Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade (Q28275315)

1

0 references

Mauricette Brocco

2

0 references

Alain Gobert

3

0 references

Anne Dekeyne

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

4

0 references

language of work or name

English

0 references

publication date

February 2005

0 references

published in

Psychopharmacology

0 references

volume

177

0 references

issue

4

0 references

page(s)

448-58

0 references

cites work

1 reference

12 December 2020

Melatonin or a melatonin agonist corrects age-related changes in circadian response to environmental stimulus

1 reference

12 December 2020

Combined effects of diazepam and melatonin in two tests for anxiolytic activity in the mouse

1 reference

12 December 2020

Peripheral-type benzodiazepine receptors: a second site of action for benzodiazepines

1 reference

12 December 2020

Neuroanatomical hypothesis of panic disorder, revised

1 reference

12 December 2020

Melatonin analogues as agonists and antagonists in the circadian system and other brain areas

1 reference

12 December 2020

N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats

1 reference

12 December 2020

Melatonin reduces anxiety induced by lipopolysaccharide in the rat.

1 reference

12 December 2020

A double blind-placebo controlled study on melatonin efficacy to reduce anxiolytic benzodiazepine use in the elderly

1 reference

12 December 2020

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

1 reference

12 December 2020

Anxiolytic-like actions of melatonin, 5-metoxytryptophol, 5-hydroxytryptophol and benzodiazepines on a conflict procedure

1 reference

12 December 2020

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety

1 reference

12 December 2020

Preclinical evaluation of the reinforcing and discriminative stimulus effects of agomelatine (S-20098), a melatonin agonist

1 reference

12 December 2020

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram

1 reference

12 December 2020

Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

1 reference

12 December 2020

Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors.

1 reference

12 December 2020

Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms

1 reference

12 December 2020

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

1 reference

12 December 2020

The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study

1 reference

12 December 2020

Pharmacological effects of melatonin treatment on both locomotor activity and brain serotonin release in rats

1 reference

12 December 2020

The neurobiology and control of anxious states

1 reference

12 December 2020

Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated

1 reference

12 December 2020

Melatonin Interaction with the Benzodiazepine-GABA Receptor Complex in the CNS

1 reference

12 December 2020

The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines

1 reference

12 December 2020

The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other an

1 reference

12 December 2020

Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats

1 reference

12 December 2020

MK-801 administration blocks the effects of a 5-HT(2A/2C) agonist on melatonin rhythmicity and c-fos induction in the suprachiasmatic nucleus

1 reference

12 December 2020

Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors

1 reference

12 December 2020

Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies

1 reference

12 December 2020

Effects of benzodiazepine agonists on punished responding in pigeons and their relationship with clinical doses in humans

1 reference

12 December 2020

Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior

1 reference

12 December 2020

Antagonistic effects of S 22153, a new mt1 and MT2 receptor ligand, on the neophobia-reducing properties of melatonin in BALB/c mice

1 reference

12 December 2020

The genetic basis of the pharmacological effects of anxiolytics: a review based on rodent models.

1 reference

12 December 2020

A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice

1 reference

12 December 2020

Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock.

1 reference

12 December 2020

5-HT1A receptor full and partial agonists and 5-HT2C (but not 5-HT3) receptor antagonists increase rates of punished responding in rats

1 reference

12 December 2020

Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics.

1 reference

12 December 2020

Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent

1 reference

12 December 2020

Chronic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels

1 reference

12 December 2020

Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS.

1 reference

12 December 2020

Effect of agomelatine in the chronic mild stress model of depression in the rat.

1 reference

12 December 2020

A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety

1 reference

12 December 2020

The pineal gland and melatonin: molecular and pharmacologic regulation

1 reference

12 December 2020

Reciprocal effects of chronic diazepam and melatonin on brain melatonin and benzodiazepine binding sites

1 reference

12 December 2020

Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

1 reference

12 December 2020

A review of 25 years of the social interaction test

1 reference

12 December 2020

GABA and the behavioral effects of anxiolytic drugs

1 reference

12 December 2020

Serotonin 5- HT (2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors

1 reference

12 December 2020

Stress-induced vocalisation in adult animals. A valid model of anxiety?

1 reference

12 December 2020

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

12 December 2020

Melatonin effects on behavior: possible mediation by the central GABAergic system.

1 reference

12 December 2020

Projections from the raphe nuclei to the suprachiasmatic nucleus of the rat.

1 reference

12 December 2020

Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat

1 reference

12 December 2020

Effects of centrally administered anxiolytic compounds in animal models of anxiety

1 reference

12 December 2020

Novel naphthalenic ligands with high affinity for the melatonin receptor

1 reference

12 December 2020

Serotonin, excitatory amino acids and the photic control of melatonin rhythms and SCN c-FOS in the rat.

1 reference

12 December 2020

Effects of melatonin on neophobic responses in different strains of mice

1 reference

12 December 2020

The role of 5-HT2C receptors in affective disorders

1 reference

12 December 2020

Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications

1 reference

12 December 2020

Role of 5-HT in stress, anxiety, and depression.

1 reference

12 December 2020

Anxiolytic-like properties of melatonin receptor agonists in mice: involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness

1 reference

12 December 2020

SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist

1 reference

12 December 2020

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

1 reference

12 December 2020

Genetic basis of anxiety-like behaviour: a critical review

1 reference

12 December 2020

Serotonin receptor gene expression in the rat suprachiasmatic nuclei.

1 reference

12 December 2020

Melatonin as an anxiolytic in rats: time dependence and interaction with the central GABAergic system

1 reference

12 December 2020